Magnus Ingelman-Sundberg, PhD; BSc.Med is Senior Professor of Molecular Toxicology and research group leader in Pharmacogenetics at the Department of Physiology and Pharmacology Karolinska Institutet
Magnus Ingelman-Sundberg, PhD; BSc.Med is Senior Professor of Molecular Toxicology and research group leader in Pharmacogenetics at the Department of Physiology and Pharmacology , Karolinska Institutet since 2006. He has more than 450 original papers, 24 500 citations (32 000 in Google Scholar) and an h-factor of 85 (ISI) or 105 (Google Scholar). He was a member of The Nobel Assembly at Karolinska Institutet 2008-2018, a Highly cited researcher 2014-2017 and a member of Editorial Advisory Boards of e.g. Trends in Pharmacological Sciences (Edit Board), Pharmacogenetics and Genomics, Pharmacogenomics, Drug Metabolism Reviews, Drug Metabolism and Disposition, Human Genomics. His research focuses on genetics, polymorphism, regulation, function and toxicology of the hepatic ADME system with aims at understanding interindividual differences in drug response. Furthermore he develops novel hepatic in vitro systems for studying liver function and validation of drug targets. Further info see: Trends Pharmacol Sci. 2015; 36:65-7 or Basic Clin Pharmacol Toxicol, 123, 643-644 Dec 2018.